OTCMKTS:HRTT

Heart Tronics Stock Forecast, Price & News

$0.02
-0.99 (-98.50 %)
(As of 04/14/2021 12:33 PM ET)
Add
Compare
Today's Range
$0.02
Now: $0.02
$0.02
50-Day Range
$0.02
MA: $0.43
$0.85
52-Week Range
$0.01
Now: $0.02
$1.00
Volume2,239 shs
Average Volume607 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta1024.78
Heart Tronics, Inc., a medical device company, engages in the research, development, and marketing of medical devices in the United States. Its medical devices are used to monitor and measure physiological signals in order to detect diseases that impact an individual's health. The company offers Fidelity 100 Monitor System, an integrated system in which its component Model 100 Patient Module collects, processes, and amplifies electrocardiogram (ECG) signals from that patient through a set of 10 electrodes that are wirelessly transmitted to the laptop computer. Its products in the development stage include Fidelity 350 Holter Monitor, an ambulatory Holter monitor that collects ECG data of arrhythmia and transient heart disease, while the patient carries out daily activities away from the physician's office or hospital. The company's products in the development stage also consist of Fidelity 200 Event Recording System/Heart Tempo Card, a non-prescription heart monitoring device, which is used as an early-detection device by patients who desire to monitor their condition. Its products also include Cardiac Vest, a lightweight, close-fitting vest or undergarment made of stretchable material in which the electrodes are stitched into the fabric; and Fidelity 400 Intracardiac Monitor that applies its proprietary physiological signal acquisition and amplification technology to read intracardiac signals procured from intracardiac catheter. The company was formerly known as Signalife, Inc. and changed its name to Heart Tronics, Inc. in November 2008. Heart Tronics, Inc. was incorporated in 1987 is headquartered in Studio City, California.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:HRTT
CUSIPN/A
CIKN/A
Phone818-432-4561
Employees13
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Headlines

No headlines for this company have been tracked by MarketBeat.com

MarketRank

Overall MarketRank

0.00 out of 5 stars

Medical Sector

1959th out of 2,019 stocks

Electromedical Equipment Industry

60th out of 61 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.02
-0.99 (-98.50 %)
(As of 04/14/2021 12:33 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HRTT News and Ratings via Email

Sign-up to receive the latest news and ratings for HRTT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Heart Tronics (OTCMKTS:HRTT) Frequently Asked Questions

What stocks does MarketBeat like better than Heart Tronics?

Wall Street analysts have given Heart Tronics a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Heart Tronics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are Heart Tronics' key executives?

Heart Tronics' management team includes the following people:
  • Dr. Budimir S. Drakulic Ph.D., Chief Scientist, VP and Director of R&D (Age 71)
  • Mr. Rowland Perkins, Chief Admin. Officer and Director (Age 86)
  • Ms. Claire Mouton LaFrance, Director of Marketing and Communications
  • Mr. James J. Mazeika, Director of Bus. Devel.
  • Mr. Kevin F. Pickard, Sec. (Age 57)

Who are some of Heart Tronics' key competitors?

What is Heart Tronics' stock symbol?

Heart Tronics trades on the OTCMKTS under the ticker symbol "HRTT."

How do I buy shares of Heart Tronics?

Shares of HRTT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Heart Tronics' stock price today?

One share of HRTT stock can currently be purchased for approximately $0.02.

How many employees does Heart Tronics have?

Heart Tronics employs 13 workers across the globe.

What is Heart Tronics' official website?

The official website for Heart Tronics is www.hearttronics.com.

Where are Heart Tronics' headquarters?

Heart Tronics is headquartered at 4705 LAUREL CANYON BLVD SUITE 203, STUDIO CITY CA, 91607.

How can I contact Heart Tronics?

Heart Tronics' mailing address is 4705 LAUREL CANYON BLVD SUITE 203, STUDIO CITY CA, 91607. The company can be reached via phone at 818-432-4561.


This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.